{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:15:58Z","timestamp":1776867358033,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.biologicals.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T17:00:38Z","timestamp":1368118838000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China"],"prefix":"10.1016","volume":"41","author":[{"given":"Matthew C.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Gibeault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilisa","family":"Filippenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2013.03.003_bib1","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.03.003_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/hv.7.2.13717","article-title":"Meningococcal glycoconjugate vaccines","volume":"7","author":"Gasparini","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.biologicals.2013.03.003_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IDR.S21545","article-title":"Meningococcal conjugate vaccines: optimizing global impact","volume":"4","author":"Terranella","year":"2011","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.biologicals.2013.03.003_bib4","series-title":"Meningococcal vaccines: WHO position paper, November 2011","first-page":"521","volume":"86","year":"2011"},{"key":"10.1016\/j.biologicals.2013.03.003_bib5","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2013.03.003_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.10.3","article-title":"The epidemiology of meningococcal disease and the impact of vaccines","volume":"9","author":"Khatami","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 2","key":"10.1016\/j.biologicals.2013.03.003_bib7","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/648964","article-title":"Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines","volume":"50","author":"Poland","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2013.03.003_bib8","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2217\/fmb.10.137","article-title":"Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults","volume":"5","author":"Pace","year":"2010","journal-title":"Future Microbiol"},{"issue":"S2","key":"10.1016\/j.biologicals.2013.03.003_bib9","doi-asserted-by":"crossref","first-page":"B30","DOI":"10.1016\/j.vaccine.2009.05.003","article-title":"Quadrivalent meningococcal conjugate vaccines","volume":"27","author":"Pace","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.03.003_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/IDR.S12716","article-title":"Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C, W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease","volume":"4","author":"Br\u00f6ker","year":"2011","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.biologicals.2013.03.003_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.147","article-title":"Menveo: a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y","volume":"10","author":"Cooper","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2013.03.003_bib12","first-page":"e56","article-title":"Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile","volume":"30","author":"Memish","year":"2011","journal-title":"J\u00a0Pediatr Dis J"},{"key":"10.1016\/j.biologicals.2013.03.003_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0929-6646(09)60371-5","article-title":"Safety and immunogenicity of a tetravalent polysaccharide vaccine against meningococcal disease","volume":"108","author":"Shao","year":"2009","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.biologicals.2013.03.003_bib14","first-page":"846756","article-title":"Conjugate meningococcal vaccines development: GSK Biologicals experience","author":"Miller","year":"2011","journal-title":"Adv Prev Med"},{"key":"10.1016\/j.biologicals.2013.03.003_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.biologicals.2013.03.003_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.6.11.12849","article-title":"Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo) or Menactra among healthy adolescents","volume":"6","author":"Gill","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.biologicals.2013.03.003_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/hv.7.2.14068","article-title":"Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults","volume":"7","author":"Bermal","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.biologicals.2013.03.003_bib18","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1093\/infdis\/136.Supplement.S78","article-title":"Structures of the capsular polysaccharide of Neisseria meningitidis as determined by 13C-nuclear magnetic resonance spectroscopy","volume":"136","author":"Jennings","year":"1977","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2013.03.003_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0731-7085(02)00462-4","article-title":"Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture","volume":"30","author":"Jones","year":"2002","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.biologicals.2013.03.003_bib20","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","article-title":"Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages","volume":"27","author":"Br\u00f6ker","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.03.003_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4155\/bio.09.181","article-title":"Bioanalysis of meningococcal vaccines","volume":"2","author":"Ravenscroft","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.biologicals.2013.03.003_bib22","unstructured":"Cook MC, Bliu A, Kunkel JP. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: Optimization of hydrolysis conditions and chromatographic methods. Vaccine, in press"},{"key":"10.1016\/j.biologicals.2013.03.003_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biologicals.2012.03.003","article-title":"MenC is working Group. Evaluation of a candidate International standard for meningococcal Group C polysaccharide","volume":"40","author":"Vipond","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2013.03.003_bib24","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/ac60119a033","article-title":"Microdetermination of phosphorus","volume":"28","author":"Chen","year":"1956","journal-title":"Anal Chem"},{"key":"10.1016\/j.biologicals.2013.03.003_bib25","unstructured":"European Pharmacopoeia. Meningococcal Polysaccharide Vaccine, 01\/2008:0250; Meningococcal Group C Conjugate Vaccine, 01\/2008:2112 corrected 6.0; Typhoid Polysaccharide Vaccine, 01\/2008:1160, Pneumococcal Polysaccharide Vaccine, 01\/2008:0966; Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed), 01\/20008:2150; Haemophilus Type b Conjugate Vaccine, 07\/2012:1219."},{"key":"10.1016\/j.biologicals.2013.03.003_bib26","unstructured":"Chinese Pharmacopoeia. Biological Products, English Edition. 2010;vol. III. Group A meningococcal polysaccharide vaccine, 48\u201352; Group A and C meningococcal polysaccharide vaccine 52\u20135; Vi polysaccharide typhoid vaccine 41\u20135; Haemophilus influenzae Type b conjugate vaccine, 55\u20139."},{"key":"10.1016\/j.biologicals.2013.03.003_bib27","article-title":"Proposal for General Chapter <1234> Vaccines for Human Use \u2013 Polysaccharide and Glycoconjugate Vaccines","volume":"39","author":"United States Pharmacopoeia \u2013 National Formulary","year":"2013","journal-title":"Pharmacopeial Forum"},{"key":"10.1016\/j.biologicals.2013.03.003_bib28","unstructured":"Chinese Pharmacopoeia. Biological products, English Edition. 2010;vol. III. Determination of phosphorus content, Appendix VII, A74; Determination of sialic acid content (Resorcinol colorimetry), Appendix VI, A54\u20135."},{"key":"10.1016\/j.biologicals.2013.03.003_bib29","unstructured":"European Pharmacopoeia. Phosphorus in polysaccharide vaccines, 01\/2008:20518; Sialic acid in polysaccharide vaccines, 01\/2008:20523."}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T03:58:57Z","timestamp":1539662337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105613000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1045105613000328"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.03.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}